Health‐related quality of life in patients with gastro‐oesophageal reflux disease under routine care: 5‐year follow‐up results of the ProGERD study
Open Access
- 12 February 2009
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 29 (6) , 662-668
- https://doi.org/10.1111/j.1365-2036.2008.03921.x
Abstract
Background Gastro‐oesophageal reflux disease (GERD) is a common disorder associated with substantial reductions in health‐related quality of life (HRQL). Aim To describe patterns of change in HRQL during 5 years of follow‐up in a large population of GERD patients. Methods In 2000, a total of 6215 GERD patients were enrolled in the Progression of GERD (ProGERD) study. During follow‐up, patients received any medication considered necessary. HRQL was assessed yearly with the Short‐Form 36 and the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaires. Associations between patient characteristics and changes in HRQL were analysed using multiple logistic regression models. Results After 5 years, data on HRQL were available for 4597 (74%) patients. Both generic and disease‐specific HRQL improved after baseline and remained well above baseline levels in the following years. A clinically relevant decrease in QOLRAD scores was reported by 3–5% of patients. According to our multivariate analysis, a decrease in HRQL was associated with a higher reflux symptom load and the presence of night‐time heartburn. Conclusions Only a small minority of the ProGERD population reported a clinically relevant decrease in HRQL, which was associated most strongly with nocturnal heartburn.Keywords
This publication has 23 references indexed in Scilit:
- Nighttime Heartburn in Patients with Gastroesophageal Reflux Disease under Routine CareDigestion, 2008
- Long‐term treatment of patients with gastro‐oesophageal reflux disease in routine care – results from the ProGERD studyAlimentary Pharmacology & Therapeutics, 2007
- Prevalence and sociodemographics of reflux symptoms in Germany – results from a national surveyAlimentary Pharmacology & Therapeutics, 2006
- Therapeutic Options in the Treatment of Nighttime Gastroesophageal RefluxDigestion, 2005
- Quality of life in acute and maintenance treatment of non‐erosive and mild erosive gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2005
- Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyJournal of Clinical Epidemiology, 2004
- Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiativeAlimentary Pharmacology & Therapeutics, 2003
- Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD StudyAlimentary Pharmacology & Therapeutics, 2003
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut, 1999
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992